Phase I dose escalation of IMC-C103C, a CD3xMAGE-A4 T-cell receptor (TCR) bispecific protein Meeting Abstract
| Authors: | Davar, D.; Sweis, R. F.; Blumenschein, G. Jr; Gutierrez, R.; Melero, I.; Chen, H. A.; Thistlethwaite, F.; Moore, K. N.; Segal, N. H.; Garralda, E.; Wilky, B.; Arkenau, H. T.; Evans, T. R. J.; Johnson, M. L.; Dar, M.; Holland, C.; Marshall, S.; Stanhope, S.; Kirk, P.; Lopez, J. S. |
| Abstract Title: | Phase I dose escalation of IMC-C103C, a CD3xMAGE-A4 T-cell receptor (TCR) bispecific protein |
| Meeting Title: | ESMO Immuno-Oncology Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2021 Dec 8-11 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-12-01 |
| Start Page: | S1411 |
| End Page: | S1413 |
| Language: | English |
| ACCESSION: | WOS:000731051400092 |
| DOI: | 10.1016/j.annonc.2021.10.109 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 91P -- Source: Wos |
